---
schema_version: "secwatch.filing_event.v1"
accession: "0001860782-24-000009"
form_type: "8-K/A"
ticker: null
cik: "0001860782"
company_name: "2seventy bio, Inc."
filed_at: "2024-02-02T23:59:59+00:00"
generated_at: "2026-06-06T10:11:00.705598+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# 2seventy bio appoints William Baird as CEO and Victoria Eatwell as CFO effective at closing

## Summary
- William D. Baird III appointed CEO; previously COO and CFO; base salary $575k, target bonus 55%.
- Baird receives initial equity grant: option for 112,500 shares and RSUs for 56,250 shares.
- Victoria Eatwell appointed CFO; previously SVP of Finance; base salary $425k, target bonus 40%.
- Eatwell receives initial equity grant: option for 85,000 shares and RSUs for 42,500 shares.
- Severance: Baird gets 1.5x base salary on change-in-control termination; Eatwell gets 1x base.

## SEC filing metadata
- accession: 0001860782-24-000009
- form_type: 8-K/A
- cik: 0001860782
- company_name: 2seventy bio, Inc.
- filed_at: 2024-02-02T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1860782/000186078224000009/0001860782-24-000009-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1860782/000186078224000009/tvst-20240129.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001860782-24-000009
- JSON: https://secwatch.observer/filing/0001860782-24-000009.json
- Plain text: https://secwatch.observer/filing/0001860782-24-000009.txt

## Key facts
- Executive change
  Victoria Eatwell was appointed as Chief Financial Officer at 2seventy bio, Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: the Board appointed Victoria Eatwell as the chief financial officer of the Company, effective as of the date of the Closing.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1860782/000186078224000009/0001860782-24-000009-index.htm
- Executive change
  William D. Baird, III was appointed as President and Chief Executive Officer at 2seventy bio, Inc..
  - Action: appointed
  - Role: President and Chief Executive Officer
  source text: the Board appointed William D. Baird, III as the president and chief executive officer of the Company, effective as of the date of the Closing.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1860782/000186078224000009/0001860782-24-000009-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.